Historique
Bulletin de Périodique
International Journal of Drug Policy , Vol.40 - February 2017 - New psychoactive substances and human enhancement drugs
Auteur(s) :
CHATWIN, C. (Éditeur scientifique) ;
MEASHAM, F. (Éditeur scientifique) ;
O'BRIEN, K. (Éditeur scientifique) ;
SUMNALL, H. (Éditeur scientifique)
Paru le :
01/02/2017
Année
2017
Page(s) :
1-122
Langue(s) :
Anglais
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Note de contenu :
CONTENTS:
- New drugs, new directions? Research priorities for new psychoactive substances and human enhancement drugs [Editorial]. Chatwin C., Measham F., O'Brien K., Sumnall H., p. 1-5.
- Social suppliers: Exploring the cultural contours of the performance and image enhancing drug (PIED) market among bodybuilders in the Netherlands and Belgium. van de Ven K., Mulrooney K.J.D., p. 6-15.
- A critical examination of the definition of ‘psychoactive effect’ in Australian drug legislation. Barratt M.J., Seear K., Lancaster K., p. 16-25.
- Have prohibition policies made the wrong decision? A critical review of studies investigating the effects of DMAA. Dunn M., p. 26-34.
- The risk environment of anabolic-androgenic steroid users in the UK: Examining motivations, practices and accounts of use. Hanley Santos G., Coomber R., p. 35-43.
- I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances. Matthews A., Sutherland R., Peacock A., Van Buskirk J., Whittaker E., Burns L., et al., p. 44-49.
- NPS and the methadone queue: Spillages of space and time. Alexandrescu L., p. 50-56.
- Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison. Ralphs R., Williams L., Askew R., Norton A., p. 57-69.
- From niche to stigma - Headshops to prison: Exploring the rise and fall of synthetic cannabinoid use among young adults. Blackman S., Bradley R., p. 70-77.
- The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin. Quintana P., Ventura M., Grifell M., Palma A., Galindo L., Fornis I., et al., p. 78-83.
- New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe. Pirona A., Bo A., Hedrich D., Ferri M., van Gelder N., Giraudon I., et al., p. 84-92.
- Health and Social Care workers' perceptions of NPS use in Northern Ireland. Campbell A., O Neill N., Higgins K., p. 93-101.
- New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors. Van Hout M.C., Hearne E., p. 102-110.
- Assessing the 'added value' of European policy on new psychoactive substances. Chatwin C., p. 111-116.
- New psychoactive substances: Are there any good options for regulating new psychoactive substances? Reuter P., Pardo B., p. 117-122.
- New drugs, new directions? Research priorities for new psychoactive substances and human enhancement drugs [Editorial]. Chatwin C., Measham F., O'Brien K., Sumnall H., p. 1-5.
- Social suppliers: Exploring the cultural contours of the performance and image enhancing drug (PIED) market among bodybuilders in the Netherlands and Belgium. van de Ven K., Mulrooney K.J.D., p. 6-15.
- A critical examination of the definition of ‘psychoactive effect’ in Australian drug legislation. Barratt M.J., Seear K., Lancaster K., p. 16-25.
- Have prohibition policies made the wrong decision? A critical review of studies investigating the effects of DMAA. Dunn M., p. 26-34.
- The risk environment of anabolic-androgenic steroid users in the UK: Examining motivations, practices and accounts of use. Hanley Santos G., Coomber R., p. 35-43.
- I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances. Matthews A., Sutherland R., Peacock A., Van Buskirk J., Whittaker E., Burns L., et al., p. 44-49.
- NPS and the methadone queue: Spillages of space and time. Alexandrescu L., p. 50-56.
- Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison. Ralphs R., Williams L., Askew R., Norton A., p. 57-69.
- From niche to stigma - Headshops to prison: Exploring the rise and fall of synthetic cannabinoid use among young adults. Blackman S., Bradley R., p. 70-77.
- The hidden web and the fentanyl problem: Detection of ocfentanil as an adulterant in heroin. Quintana P., Ventura M., Grifell M., Palma A., Galindo L., Fornis I., et al., p. 78-83.
- New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe. Pirona A., Bo A., Hedrich D., Ferri M., van Gelder N., Giraudon I., et al., p. 84-92.
- Health and Social Care workers' perceptions of NPS use in Northern Ireland. Campbell A., O Neill N., Higgins K., p. 93-101.
- New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors. Van Hout M.C., Hearne E., p. 102-110.
- Assessing the 'added value' of European policy on new psychoactive substances. Chatwin C., p. 111-116.
- New psychoactive substances: Are there any good options for regulating new psychoactive substances? Reuter P., Pardo B., p. 117-122.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
Nouveauté
![New drugs, new directions? Research priorities for new psychoactive substances and human enhancement drugs [Editorial]](https://bdoc.ofdt.fr/img_cache/pmb_ofdt_record_78785.webp?v=1771255638)
C. CHATWIN ;
F. MEASHAM ;
K. O'BRIEN ;
H. SUMNALL
|
2017
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
This special issue of the International Journal of Drug Policy focuses on 'new drugs', drawing on contributions to an Economic and Social Research Council (ESRC) seminar series (https://newdrugseminars.wordpress.com). [Extract]
Nouveauté
A. MATTHEWS ;
R. SUTHERLAND ;
A. PEACOCK ;
J. VAN BUSKIRK ;
E. WHITTAKER ;
L. BURNS ;
R. BRUNO
|
2017
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Background: Over the past decade, monitoring systems have identified the rapid emergence of new psychoactive substances (NPS). While the use of many NPS is minimal and transitory, little is known about which products have potential for capturing[...]
Nouveauté
S. BLACKMAN ;
R. BRADLEY
|
2017
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
The aim of this paper will be to consider the rise and subsequent fall in NPS use at national and local level with a focus on synthetic cannabinoid products in Kent. We will examine the local practice and policy responses by Kent's Young Persons[...]
Nouveauté
A. PIRONA ;
A. BO ;
D. HEDRICH ;
M. FERRI ;
N. VAN GELDER ;
I. GIRAUDON ;
L. MONTANARI ;
R. SIMON ;
J. MOUNTENEY
|
2017
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Background: The availability of new psychoactive substances (NPS) in Europe has rapidly increased over the last decade. Although prevalence levels of NPS use remain low in the general European population, there are serious concerns associated wi[...]
Nouveauté
A. CAMPBELL ;
N. O NEILL ;
K. HIGGINS
|
2017
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Background: The EU Early Warning System currently monitors more than 560 new psychoactive substances, far outweighing the total number of illicit drugs under international control. Due to the recent emergence of NPS and rapidly changing nature o[...]
Nouveauté
M. C. VAN HOUT ;
E. HEARNE
|
2017
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Background: The continual diversification of new psychoactive substances (NPS) circumventing legislation creates a public health and law enforcement challenge, and one particularly challenged by availability on Hidden Web cryptomarkets.
Methods[...]
Nouveauté
C. CHATWIN
|
2017
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Background: New psychoactive substances (NPS) are reported to be on the rise throughout Europe, and are often presented as the latest challenge facing drug-policy makers. At the European level, legislation on NPS has existed since 1998. Several [...]
Nouveauté
P. REUTER ;
B. PARDO
|
2017
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Dans International Journal of Drug Policy (Vol.40, February 2017) Article : Périodique
Advances in chemistry, technology, and globalization have contributed to the rapid development and diffusion of NPS (new psychoactive substances), creating perhaps the most serious challenge to the century-old international drug control system a[...]